Skip to main content

Table 1 Baseline clinical parameters of the study population

From: Comparison of the proximal and distal approaches for axillary vein catheterization under ultrasound guidance (PANDA) in cardiac surgery patients susceptible to bleeding: a randomized controlled trial

 

Proximal group (n = 99)

Distal group (n = 99)

p value

Gender (male), n (%)

72 (72.7)

60 (60.6)

0.10

Age (years)

62 (53, 69)

60 (47, 68)

0.29

Body mass index (kg/m2)

24 ± 4.8

23.4 ± 4.0

0.34

Type of surgery, n (%)

 CABG only

17 (17.2)

12 (12.1)

0.42

 Valve only

26 (26.3)

37 (37.4)

0.13

 CABG and valve

10 (10.1)

8 (8.1)

0.81

 Aortic surgery

31 (31.3)

28 (28.3)

0.77

 Other cardiac surgery

15 (15.2)

14 (14.1)

1.00

EuroScore

6 (4, 7)

6 (3, 8)

0.66

Single antiplatelet drug administration, n (%)

10 (10.1)

17 (17.2)

0.21

Dural antiplatelet drugs administration, n (%)

17 (17.2)

13 (13.1)

0.55

Anticoagulants administration only, n (%)

62 (62.6)

61 (61.6)

1.00

Antiplatelet drug and anticoagulants administration, n (%)

10 (10.1)

8 (8.1)

0.81

Reasons for catheterization, n (%)

 Tracheostomy

57 (57.6)

59 (59.6)

0.89

 Hemodynamic monitoring

26 (26.3)

18 (18.2)

0.23

 Catheter dysfunction

11 (11.1)

16 (16.2)

0.41

 Suspicion of bloodstream infection

5 (5.1)

6 (6.1)

1.00

 Patients on ECMO, n (%)

3 (3.0)

5 (5.1)

0.72

 Patients on IABP, n (%)

3 (3.0)

5 (5.1)

0.72

 Patients on RRT, n (%)

38 (38.4)

33 (33.3)

0.55

 Duration of invasive mechanical ventilation, days

11 (6, 18)

11 (6, 19)

0.73

 Median length of ICU stay, days

19 (12, 31)

18 (10, 26)

0.29

 Median length of hospital stay, days

33 (23, 48)

29 (20, 43)

0.10

 ICU mortality, n (%)

15 (15.2)

20 (20.2)

0.46

 Hospital mortality, n (%)

16 (16.2)

22 (22.2)

0.37

  1. Continuous data are presented as the mean (SD) or median (IQR). Categorical data are presented as counts (%)
  2. CABG coronary artery bypass grafting, ECMO extracorporeal membrane oxygenation, IABP intra-aortic balloon pump, RRT renal replacement therapy